ThinkBio.Ai® Launches ThinkBio Sidney™, an AI-Driven Oncology Expert Agent at AACR 2026 We are excited to announce the launch of ThinkBio Sidney™, our next-generation oncology expert agent, unveiled at the AACR Annual Meeting 2026 in San Diego (Booth #4922). Sidney™ is a knowledge-infused, multi-agent AI platform designed to accelerate the journey from research to real-world evidence by enabling faster, more confident R&D decision-making. Sidney™ integrates multi-omics data, scientific literature, and clinical evidence to transform complex biological data into interpretable, mechanism-driven insights across the drug development lifecycle. By connecting target–disease–drug mechanisms with clinical outcomes, Sidney™ helps researchers: ➡️ Improve go/no-go decision-making ➡️ Understand tumor heterogeneity and biomarkers of response ➡️ Build evidence-based and explainable decision models ➡️ Accelerate translational oncology research Request a live demo or explore Sidney™ at Booth #4922 during AACR 2026 or connect with us for a virtual walkthrough. Read the full press release: https://lnkd.in/gt4WCSaY #AACR2026 #OncologyAI #DrugDiscovery #Biotech #AIinHealthcare #ThinkBioAI #PrecisionMedicine #WeAreThinkers Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe |Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming | Dr.Arun Abraham | Sreeraj Nandilath | Sruthy Jacob
ThinkBio.Ai®, Inc.
Biotechnology Research
Your partner in AI-driven computable biology company transforming drug discovery and clinical research.
About us
ThinkBio.Ai® is an AI-driven product company developing advanced platforms for drug discovery, biomedical research, and precision medicine. The company builds intelligent software systems that transform complex biological and clinical data into computable knowledge, enabling faster scientific discovery and data-driven healthcare decisions. ThinkBio.Ai® delivers specialized solutions across the biomedical and healthcare value chain. For biopharma, our platforms help de-risk drug development through products such as ThinkBio R-COP™, TrialFit.Ai®, DrugSuccess.Ai™, and DrugReboot.Ai™, enabling better insight generation, clinical trial optimization, and translational decision-making. For healthcare and precision medicine, solutions including Patient Panorama™, Healia, and Advice & Guide® support clinical intelligence, patient-centered care, and data-driven healthcare delivery. Together, these technologies combine artificial intelligence, biological knowledge graphs, and privacy-preserving infrastructure to uncover meaningful insight from fragmented biomedical information. By enabling organizations to integrate, interpret, and translate complex biological systems, ThinkBio.Ai® helps biopharma companies, research institutions, and healthcare providers accelerate discovery, reduce translational risk, and advance precision medicine.
- Website
-
https://thinkbio.ai/
External link for ThinkBio.Ai®, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Type
- Privately Held
- Founded
- 2024
Employees at ThinkBio.Ai®, Inc.
Updates
-
The ThinkBio.Ai® team is in San Diego for AACR 2026. Do come by Booth 4922 to connect with our team and learn more about DrugSuccess. Ai™, TrialFit. Ai®, and DrugReboot. Ai™, platforms designed to help de-risk drug development and improve clinical trial success through data-driven insights. You can also hear from Amit Chaudhuri PhD, Chief Scientific Officer, along with Anand Aravind, Director of Business Development (US), as they share how ThinkBio.Ai® is supporting derisking drug development lifecycle as well as increasing clinical trial success. We look forward to connecting with researchers, clinicians, and biopharma leaders throughout the event. #AACR #AACR2026 #DrugDevelopment #ClinicalTrials #Biopharma #AIinHealthcare #WeAreThinkers
-
-
We’re excited to share that ThinkBio.Ai® will be attending the AACR Annual Meeting in San Diego this year. We’re looking forward to connecting with researchers, clinicians, and industry leaders who are passionate about advancing drug development and clinical research. If you’ll be there, we’d love to meet and exchange ideas. #AACR2026 #CancerResearch #Oncology #ClinicalTrials #DrugDevelopment #TranslationalScience #Biotech #Pharma #AIinHealthcare #PrecisionMedicine #WeAreThinkers Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe | Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming | Dr.Arun Abraham | Aparna K.| Sreeraj Nandilath | Sruthy Jacob | Arali Nair
-
Why "Retrieval" is Not "Reasoning" in Oncology Generic AI can summarize a paper on PD-1 inhibitors. But can it tell you why a specific patient cohort is failing a trial based on sub-threshold biomarker signals? At AACR 2026 in San Diego, we are officially launching ThinkBio Sidney™, our Oncology Expert Agent. Built on our TheraBluePrint® platform, Sidney doesn’t just read data—it computes cancer biology. Visiting AACR? Meet us at our booth to see Sidney in action. Message us directly to book a private demo at the booth. #AACR26 #OncologyAI #ThinkBioSidney #DrugDiscovery #PrecisionMedicine #WeAreThinkers Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe | Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming | Dr.Arun Abraham | Sreeraj Nandilath | Sruthy Jacob
-
-
World Health Day! Today, we celebrate innovation, collaboration, and evidence led progress because better health outcomes start with trust in science. At ThinkBio.Ai ®, we believe health and science go hand in hand transforming biological complexity into real world impact for patients, clinicians, and researchers alike. Our AI powered platforms harness data, biological insight, and clinical intelligence to help accelerate discovery and improve care across biopharma and healthcare. Here’s to a healthier, more equitable future for all! #WorldHealthDay #HealthForAll #StandWithScience #AIinHealthcare #PrecisionMedicine #WeAreThinkers
-
-
ThinkBio.Ai® Launches EMIL™ — A NextGen AI Immune Expert Agent We’re excited to announce the launch of ThinkBio EMIL™ — an AI driven immune expert agent built to accelerate discovery in immune-mediated inflammatory diseases (IMIDs). EMIL combines immune omics, curated scientific literature, and cross disease insights within a multiagent scientific reasoning platform to support deeper mechanistic understanding, biomarker discovery, and therapeutic research. Built on ThinkBio’s TheraBluePrint® Immunology platform, EMIL introduces a new paradigm for AI in life sciences where specialized agents work together to interpret complex biological systems and generate testable translational hypotheses. Early access is now available for select partners and research organizations in the United States marking a major step forward in how AI empowers scientific discovery. Read our press release here: https://lnkd.in/gd5tYFNv For more information visit the website: https://lnkd.in/gfKZF_5R Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe | Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming | Dr.Arun Abraham #AIinHealthcare #LifeSciences #BioTech #AIinResearch #ImmuneBiology #Innovation #TranslationalScience #WeAreThinkers
-
-
As we celebrate this season of renewal and hope, we want to take a moment to express our gratitude to our amazing team, partners, and community. Easter is a time for fresh beginnings, reflection, and growth, values that inspire everything we do at ThinkBio.Ai®. May this season bring positivity, new opportunities, and a renewed sense of energy in both your personal and professional life. Here’s to embracing change, fostering innovation, and creating meaningful impact together! Wishing everyone a joyful and refreshing Easter! #Easter2026 #ThinkBio #Renewal #Growth #Innovation #Teamwork #Gratitude #WeAreThinkers
-
Together for Smarter, Faster Cancer Breakthroughs. ThinkBio.Ai® is attending the AACR Annual Meeting, joining the world’s leading cancer researchers and clinicians to advance the future of translational science. Whether you’re predicting therapeutic success, reviving a failed oncology program, or accelerating clinical enrolment, ThinkBio.Ai® helps you de-risk drug development and increase clinical trial success. Meet us in San Diego | Booth 4922 | April 17 – 22, 2026 #AACR2026 #CancerResearch #Oncology #ClinicalTrials #DrugDevelopment #TranslationalScience #Biotech #Pharma #AIinHealthcare #PrecisionMedicine #WeAreThinkers Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe | Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming | Dr.Arun Abraham | Aparna K. | Manoj Krishnan | Sreeraj Nandilath | Sruthy Jacob
-
What if a single change in a protein could predict disease before symptoms appear? Proteins drive nearly every biological process, and even one small mutation can alter how they fold and function. Today, AI-powered structural biology is helping researchers predict these changes, understand disease mechanisms, and accelerate drug discovery faster than ever before. Watch our latest video and explore more in our article: https://lnkd.in/gMPTXmWR #AIinHealthcare #StructuralBiology #ProteinFolding #PrecisionMedicine #DrugDiscovery #Bioinformatics #FutureOfHealthcare #WeAreThinkers Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe | Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming
-
How many eligible patients are never matched to the right clinical trial? The challenge isn’t availability, it’s alignment! With TrialFit. Ai®, we are bridging this gap. By structuring patient data and aligning it with active trials, it enables fast, evidence-based matching with clear eligibility logic. Faster matching, better enrollment, and fewer missed opportunities. Curious how this works in practice? Learn more → https://lnkd.in/gcpJHigq #DigitalHealth #ClinicalResearch #AIinHealthcare #PrecisionMedicine #TrialMatching #WeAreThinkers Pradeep Palazhi | Amit Chaudhuri | Apurva Kalia | Suniti Ponkshe | Anand Aravind | John Rekesh | Michael Evans | Kevin Fleming